Optimal crossover designs for logistic regression models in pharmacodynamics.
T H Waterhouse1, J A Eccleston, S B Duffull
1School of Physical Sciences, University of Queensland, Brisbane, Australia. t.waterhouse@gmail.com
Journal of Biopharmaceutical Statistics
|December 7, 2006
Summary
This study introduces optimal designs for drug dose-ranging trials, enhancing efficiency and flexibility. These designs improve upon traditional methods for binary outcomes, considering carryover effects in pharmacodynamics.
Area of Science:
- Pharmacodynamics
- Clinical Trial Design
- Biostatistics
Background:
- Pharmacodynamics (PD) investigates drug effects on the body.
- Dose-ranging trials are crucial for determining optimal drug dosages.
- Binary outcomes (success/failure) are common in clinical trials.
Purpose of the Study:
- To develop and evaluate optimal designs for multi-period dose-ranging trials.
- To compare the efficiency of optimal designs against balanced designs.
- To assess the robustness of optimal designs to parameter misspecification.
Main Methods:
- Utilized a logistic regression model for binary response data.
- Investigated parallel (single-period) and crossover (two-period) trial designs.
- Incorporated carryover effects proportional to direct drug effects.
Main Results:
- Optimal parallel and crossover designs demonstrated substantially greater efficiency than balanced designs.
- Optimal designs proved robust even when model parameters were misspecified.
- Combining parallel and crossover designs offers enhanced experimental flexibility.
Conclusions:
- Optimal designs represent a significant advancement for dose-ranging trials.
- The robustness and efficiency of these designs support their practical application.
- Future research can leverage these designs for more flexible and informative clinical studies.
Related Concept Videos
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
01:14Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...